Petros V. Anagnostopoulos, MD, MBA, FACS

Professor

  • Surgeon in Chief, American Family Children’s Hospital
  • Chief, Section of Pediatric Cardiothoracic Surgery
  • Division of Cardiothoracic Surgery

petros@surgery.wisc.edu
(608) 262-3858

600 Highland Ave.
BX3236
Madison, WI 53792-0001

Education

  • MD, University of Athens Medical School, Athens Greece, 1994
  • Residency in General Surgery, Henry Ford Hospital, Detroit, MI, 1997
  • Postdoctoral Fellowship, Heart and Vascular Institute of Henry Ford Hospital, Detroit, MI, 2002
  • Residency in Cardiothoracic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, 2004
  • Fellowship in Pediatric Cardiac Surgery, University of California San Francisco School of Medicine, San Francisco, CA, 2006

Clinical Specialties

Dr. Anagnostopoulos specializes in complex neonatal and infant cardiac reconstructive surgery, pediatric heart surgery, adult congenital cardiac surgery, single ventricle palliation, extracorporeal life support, extracorporeal membrane oxygenation, ventricular assist devices, minimally invasive cardiac surgery, hybrid surgical-catheterization cardiac surgery, off-pump cardiac surgery, complex mitral and tricuspid valve repair, aortic root surgery, tetralogy of Fallot, coronary artery anomalies, Ross operations, obstructive cardiomyopathy, and heart transplantation.

Dr. Anagnostopoulos provides a wide range of services including Neonatal and Infant Cardiac Reconstructive Surgery, Pediatric Heart Surgery, Adult Congenital Cardiac Surgery, Single Ventricle Palliation, Extracorporeal Life Support, Ventricular Assist Devices, Minimally Invasive Cardiac Surgery, Hybrid Surgical-Catheterization Cardiac Surgery, Off-Pump Cardiac Surgery, Complex Mitral and Tricuspid Valve Repair, Aortic Root Surgery, Tetralogy of Fallot, Coronary Artery Anomalies, Ross Operations, Obstructive Cardiomyopathy, Heart Transplant.

Research Interests

Dr. Anagnostopoulos’s research interests include coagulopathy associated with supraceliac aortic clamping and development of rapid deployment extracorporeal life support program.

Recent Publications

  • Nicardipine Is a Safe, Efficacious, and Cost-Effective Antihypertensive for Neonates and Young Infants Undergoing Cardiac Surgery.
    Lushaj E, Hermsen JL, Nelson K, Amond K, Bogenschutz M, Arndt S, Wilhelm M, Anagnostopoulos PV
    World J Pediatr Congenit Heart Surg 2022 05; 13(3): 341-345
    [PubMed ID: 35446217]

  • Commentary: Obstruction or No Obstruction? That Is the Question. Is CT the Answer We've Been Searching for?
    Allen CC, Anagnostopoulos PV
    Semin Thorac Cardiovasc Surg 2022 Mar 21;
    [PubMed ID: 35331897]

  • Is Porcine Small Intestinal Submucosal Extracellular Matrix (ECM) a Suitable Material for Right Ventricular Outflow Tract Reconstruction in Association With Pulmonary Valve Replacement?
    Burke CR, Lewis E, Schreiter NA, Bartlett H, Krieger EV, Anagnostopoulos PV, Verrier ED, Hermsen JL
    World J Pediatr Congenit Heart Surg 2022 Jan 05; 21501351211069559
    [PubMed ID: 34985359]

  • The Use of Alveolar Dead Space Fraction to Predict Postoperative Outcomes after Pediatric Cardiac Surgery: A Retrospective Study.
    Sayed IA, Hagen S, Rajamanickam V, Anagnostopoulos PV, Eldridge M, Al-Subu A
    Pediatr Cardiol 2021 Dec; 42(8): 1826-1833
    [PubMed ID: 34244822]

  • The Use of STS Public Reporting to Guide Referrals in Congenital Heart Surgery: Results of a Survey.
    Schreiter N, Hermsen J, Hokanson J, Anagnostopoulos PV
    Ann Thorac Surg 2021 Jul 06;
    [PubMed ID: 34237290]

All Publications on PubMed